
Alzheimer’s drug slows progression of cognitive decline in clinical trial, drugmakers say
By Amanda Sealy, CNN A monoclonal antibody treatment for Alzheimer’s disease called lecanemab slows the progression of cognitive decline by 27%…
Continue Reading